You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 6,294,540


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,294,540
Title: Carbocyclic nucleoside hemisulfate and its use in treating viral infections
Abstract:The hemisulfate salt of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene- 1-methanol or a solvate of it is used in the treatment of viral infections.
Inventor(s): Brodie; Alastair Couper (London, GB), Jones; Martin Francis (Kneloworth, GB), Seager; John Frederick (Ware, GB), Wallis; Christopher John (Rayston, GB)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:09/423,982
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Formulation; Dosage form; Process;
Patent landscape, scope, and claims:

United States Patent 6,294,540: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,294,540, titled "Carbocyclic nucleoside hemisulfate and its use in treating viral infections," is a significant patent in the pharmaceutical field, particularly in the treatment of viral infections such as HIV and HBV. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes a novel salt of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol or a solvate thereof. This compound is specifically designed for the treatment of viral infections, including HIV and HBV[4][5].

Pharmaceutical Formulations and Uses

The patent outlines the preparation and use of this compound in pharmaceutical formulations. It highlights the advantages of the hemisulfate salt over other salts, such as ease of preparation and crystallization, which are crucial for pharmaceutical formulation and tableting[4].

Scope of the Patent

Claim Scope

The claims in the patent are critical for defining the scope of protection. The patent includes claims for the compound itself, its pharmaceutical formulations, and methods for treating viral infections using this compound. It is important to note that the claim scope must be balanced; overly broad claims can be difficult to get granted and may be easier to invalidate, while too narrow claims may not provide sufficient protection[3].

Prior Art and Novelty

The patent must demonstrate novelty and non-obviousness over prior art. In this case, the hemisulfate salt is a new entity that offers specific advantages over previously known salts, such as the succinate salt described in PCT Patent Application No. PCT/GB95/02014[4].

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. For example, the patent claims the compound itself and then narrows down to specific methods of preparation and use[4].

Risk of Invalidation

Overly broad claims can risk invalidation under the abstract idea exception or failure to meet the written description requirement. The Federal Circuit has emphasized that claims must be anchored to the embodiments in the disclosure to avoid such risks[3].

Patent Landscape

Global Patent Family

The patent is part of a global patent family, with related applications filed in various countries. Tools like the Global Dossier provided by the USPTO can help track the patent family and access file histories of related applications from participating IP Offices[1].

International Search and Examination

The patent landscape includes international search and examination reports. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can be used to search for similar patents and prior art globally[1].

Expiration and Generic Entry

Patent Expiration

The patent has expired, which means that the exclusive rights to the invention have lapsed, and the technology is now in the public domain. This allows generic manufacturers to produce and market similar products without infringing on the original patent[2].

Impact on Generic Entry

The expiration of the patent opens the market to generic versions of the drug, which can significantly reduce costs for patients. Generic entry is a critical aspect of the pharmaceutical industry, as it increases access to life-saving medications[2].

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. The Public Search Facility and Patent and Trademark Resource Centers (PTRCs) also offer valuable resources for conducting thorough patent searches[1].

International Databases

International databases such as esp@cenet by the EPO, PATENTSCOPE by WIPO, and others provide access to global patent collections. These resources are essential for understanding the broader patent landscape and identifying potential prior art[1].

Key Takeaways

  • Balanced Claim Scope: The claim scope must be balanced to avoid invalidation risks and ensure sufficient protection.
  • Global Patent Family: Understanding the global patent family is crucial for tracking related applications and accessing file histories.
  • Expiration and Generic Entry: The expiration of the patent allows for generic entry, increasing access to affordable medications.
  • Search and Analysis Tools: Utilizing USPTO and international databases is essential for thorough patent searches and analysis.

FAQs

What is the main subject of United States Patent 6,294,540?

The main subject of United States Patent 6,294,540 is a novel salt of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol or a solvate thereof, used in treating viral infections such as HIV and HBV.

How important is the claim scope in a patent application?

The claim scope is crucial as it defines the protection granted by the patent. Overly broad claims can be difficult to get granted and may be easier to invalidate, while too narrow claims may not provide sufficient protection.

What tools can be used to search for related patents globally?

Tools such as the Global Dossier, Patent Public Search, and international databases like esp@cenet by the EPO and PATENTSCOPE by WIPO can be used to search for related patents globally.

What happens when a patent expires?

When a patent expires, the exclusive rights to the invention lapse, and the technology enters the public domain, allowing generic manufacturers to produce and market similar products without infringing on the original patent.

Why is it important to conduct a thorough patent search?

Conducting a thorough patent search helps identify prior art, ensures novelty and non-obviousness of the invention, and avoids potential infringement issues.

Sources

  1. USPTO: Search for patents - USPTO
  2. DrugPatentWatch: Pharmaceutical drugs covered by patent 6,294,540
  3. Rimon Law: The Importance of Getting the Claim Scope Right in a US Patent Application
  4. Google Patents: US6294540B1 - Carbocyclic nucleoside hemisulfate and its use in treating viral infections
  5. PubChem: Carbocyclic nucleoside hemisulfate and its use in treating viral infections

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,294,540

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,294,540

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9709945May 17, 1997
PCT Information
PCT FiledMay 14, 1998PCT Application Number:PCT/EP98/02835
PCT Publication Date:November 26, 1998PCT Publication Number: WO98/52949

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.